451 related articles for article (PubMed ID: 18613456)
21. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K
Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
[TBL] [Abstract][Full Text] [Related]
22. Macroscopic Borrmann type as a simple prognostic indicator in patients with advanced gastric cancer.
Li C; Oh SJ; Kim S; Hyung WJ; Yan M; Zhu ZG; Noh SH
Oncology; 2009; 77(3-4):197-204. PubMed ID: 19729977
[TBL] [Abstract][Full Text] [Related]
23. Significant prognostic factors in patients with node-negative gastric cancer.
Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
Int Surg; 1999; 84(4):331-6. PubMed ID: 10667813
[TBL] [Abstract][Full Text] [Related]
24. Lymph node metastasis in early gastric cancer: a clinicopathological analysis.
Wu CY; Chen JT; Chen GH; Yeh HZ
Hepatogastroenterology; 2002; 49(47):1465-8. PubMed ID: 12239968
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China.
Song W; Wu SJ; He YL; Cai SR; Zhang CH; Zhang XH; Zhan WH
Chin Med J (Engl); 2009 Jul; 122(13):1486-91. PubMed ID: 19719934
[TBL] [Abstract][Full Text] [Related]
26. Survival predictors in patients with node-negative gastric carcinoma.
Lee CC; Wu CW; Lo SS; Chen JH; Li AF; Hsieh MC; Shen KH; Lui WY
J Gastroenterol Hepatol; 2007 Jul; 22(7):1014-8. PubMed ID: 17608847
[TBL] [Abstract][Full Text] [Related]
27. Relations of proliferative activities of gastric carcinoma cells to lymphatic involvement, venous invasion and prognosis.
Wu YF; Xu HM; Chen JQ
Chin Med J (Engl); 2004 Oct; 117(10):1530-5. PubMed ID: 15498378
[TBL] [Abstract][Full Text] [Related]
28. Lymph node metastasis as a single predictor in patients with Borrmann type I gastric cancer.
Chen JH; Wu CW; Lo SS; Li AF; Hsieh MC; Shen KH; Lui WY
Hepatogastroenterology; 2007; 54(75):981-4. PubMed ID: 17591108
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathologic features of gastric carcinoma patients who undergo a total gastrectomy.
Joo JK; Kim HG; Ryu SY; Lee JH; Kim DY
Int Surg; 2010; 95(2):147-52. PubMed ID: 20718322
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic strategy for patients with pN0 gastric carcinoma.
Kunisaki C; Shimada H; Nomura M; Matsuda G; Otsuka Y; Ono H; Akiyama H
J Surg Oncol; 2006 Sep; 94(3):212-9. PubMed ID: 16900514
[TBL] [Abstract][Full Text] [Related]
31. Regional lymph node metastasis as a predictor of peritoneal carcinomatosis in patients with Borrmann type IV gastric carcinoma.
Otsuji E; Yamaguchi T; Sawai K; Sakakura C; Okamoto K; Takahashi T
Am J Gastroenterol; 1999 Feb; 94(2):434-7. PubMed ID: 10022642
[TBL] [Abstract][Full Text] [Related]
32. Tumor size predicts survival in mucinous gastric carcinoma.
Sung CO; Lee SM; Choi JS; Kim KM; Choi MG; Noh JH; Sohn TS; Bae JM; Kim WH; Park CK; Kim S
J Surg Oncol; 2012 Nov; 106(6):757-64. PubMed ID: 22535583
[TBL] [Abstract][Full Text] [Related]
33. Peritoneal carcinomatosis and lymph node metastasis are prognostic indicators in patients with Borrmann type IV gastric carcinoma.
Chen CY; Wu CW; Lo SS; Hsieh MC; Lui WY; Shen KH
Hepatogastroenterology; 2002; 49(45):874-7. PubMed ID: 12064011
[TBL] [Abstract][Full Text] [Related]
34. Strong association of lymph node metastasis with intraperitoneal free cancer cell (IFCC) in advanced gastric cancer.
Yamashita K; Sakuramoto S; Kikuchi S; Katada N; Kobayashi N; Watanabe M
Hepatogastroenterology; 2008; 55(86-87):1873-7. PubMed ID: 19102412
[TBL] [Abstract][Full Text] [Related]
35. Predictors of long-term survival in large gastric carcinoma patients.
Zhang M; Li Z; Zhao B; Wei Y; Zhu G; Ma Y; Xue Y
Hepatogastroenterology; 2011; 58(112):2162-5. PubMed ID: 22234086
[TBL] [Abstract][Full Text] [Related]
36. Mucinous gastric cancer presents with more advanced tumor stage and weaker β-catenin expression than nonmucinous cancer.
Choi MG; Sung CO; Noh JH; Kim KM; Sohn TS; Kim S; Bae JM
Ann Surg Oncol; 2010 Nov; 17(11):3053-8. PubMed ID: 20645013
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of macroscopic serosal invasion in advanced gastric cancer.
Yasuda K; Shiraishi N; Inomata M; Shiroshita H; Izumi K; Kitano S
Hepatogastroenterology; 2007; 54(79):2028-31. PubMed ID: 18251153
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological characteristics of signet ring cell carcinoma of the stomach.
Kim DY; Park YK; Joo JK; Ryu SY; Kim YJ; Kim SK; Lee JH
ANZ J Surg; 2004 Dec; 74(12):1060-4. PubMed ID: 15574148
[TBL] [Abstract][Full Text] [Related]
39. Mucinous breast carcinoma: a large contemporary series.
Barkley CR; Ligibel JA; Wong JS; Lipsitz S; Smith BL; Golshan M
Am J Surg; 2008 Oct; 196(4):549-51. PubMed ID: 18809061
[TBL] [Abstract][Full Text] [Related]
40. Relation of proliferative activity to survival in patients with advanced gastric cancer.
Yonemura Y; Kamata T; Ohoyama S; Matumoto H; Kimura H; Kosaka T; Yamaguchi A; Miwa K; Miyazaki I
Anal Cell Pathol; 1991 Mar; 3(2):103-10. PubMed ID: 2025600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
